Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTritax Eurobox Regulatory News (EBOX)

Share Price Information for Tritax Eurobox (EBOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.30
Ask: 61.80
Change: 2.30 (3.89%)
Spread: 0.50 (0.816%)
Open: 59.20
High: 61.50
Low: 59.20
Prev. Close: 59.20
EBOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - TRITAX EUROBOX PLC ORD

18 Jun 2024 12:34

RNS Number : 9105S
Evelyn Partners Group Limited
18 June 2024
 

FORM 8.3

 

DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Evelyn Partners Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TRITAX EUROBOX PLC ORD

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17/06/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

GBP0.01

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

17,852,520

2.21%

 

 

(2) Cash-settled derivatives:

 

N/A

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

 

 

 

TOTAL:

 

17,852,520

2.21%

 

 

 

All interests and all short positions should be disclosed

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (£)

0.01

Sale

15,000

0.67

0.01

Sale

10,300

0.57

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

18.06.2024

 

Contact name:

Jane Dias

Risk and Compliance

Evelyn Partners Limited

Telephone number:

+44 20 7131 4952

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSFSFFAELSEDM
Date   Source Headline
20th Nov 20207:00 amRNSNotice of Full Year Results
17th Nov 20205:15 pmRNSHolding(s) in Company
25th Aug 202010:39 amRNSHolding(s) in Company
19th Aug 20206:17 pmRNSExchange Rate for Dividend Payment
18th Aug 20201:52 pmRNSHolding(s) in Company
4th Aug 202011:35 amRNSRent collection/Investment update/Interim dividend
17th Jul 20202:36 pmRNSHolding(s) in Company
1st Jul 202010:46 amRNSHolding(s) in Company
18th Jun 20209:48 amRNSPurchase of Management Shares
4th Jun 20201:58 pmRNSExchange Rate for Dividend Payment
21st May 20204:04 pmRNSHolding(s) in Company
21st May 202011:51 amRNSDirectorship Update
19th May 20207:01 amRNSHalf Year Results
19th May 20207:00 amRNSDividend Declaration
18th May 20209:46 amRNSHolding(s) in Company
13th May 20205:35 pmRNSHolding(s) in Company
13th May 202011:32 amRNSNotice of Half Year Results
7th May 20203:09 pmRNSHolding(s) in Company
5th May 20204:36 pmRNSBoard Committee Changes
29th Apr 20207:00 amRNSStatement on COVID-19 and Notice of HY Results
3rd Apr 20208:48 amRNSHolding(s) in Company
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:42 pmRNSPrice Monitoring Extension
17th Mar 20207:52 amRNSLand Sale in Bornem, Belgium
13th Mar 202012:39 pmRNSDirector/PDMR Shareholding
12th Mar 20204:46 pmRNSHolding(s) in Company
11th Mar 20203:53 pmRNSExchange Rate For Dividend Payment
10th Mar 20206:10 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSTrading Update and EPRA Index Inclusion
6th Mar 20205:09 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSHolding(s) in Company
14th Feb 20207:00 amRNSDividend Declaration
13th Feb 202012:35 pmRNSResult of AGM
6th Feb 20203:57 pmRNSPurchase of Management Shares
3rd Feb 20207:00 amRNSAcquires two new prime assets & adjacent land
29th Jan 20205:41 pmRNSDirectorship Update
17th Jan 20204:00 pmRNSNotice of AGM
7th Jan 20207:00 amRNSNew lease completion at asset in Germany
3rd Jan 202010:53 amRNSExchange Rate For Dividend Payment
27th Dec 20197:00 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSAcquires new asset in the Netherlands
16th Dec 201912:52 pmRNSChange of Registered Office
10th Dec 20197:00 amRNSAppointment of Non-Executive Director
10th Dec 20197:00 amRNSInterim Dividend Declaration
10th Dec 20197:00 amRNSResults to 30 Sept 2019
27th Nov 20192:00 pmRNSFunding extension of Mango asset in Barcelona
20th Nov 20193:48 pmRNSNotice of Results
18th Oct 20199:08 amRNSHolding(s) in Company
30th Sep 20197:00 amRNSEUR125m incremental increase in bank facility
24th Sep 20197:00 amRNSAcquires two new big box assets in Bremen, Germany

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.